Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Masahiko Kajiwara"'
Autor:
Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Yoichi Yano, Satoru Matsugaki, Etsuko Moriyama, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12325-12335 (2023)
Abstract Background and Aims We aimed to validate the predictive factors for tumor response and the prognostic impact of conversion therapy aimed at cancer‐ and drug‐free states in patients with unresectable hepatocellular carcinoma (u‐HCC) und
Externí odkaz:
https://doaj.org/article/26571559f9b244bc907903ba1baffeb9
Autor:
Shigeo Shimose, Atsushi Hiraoka, Masahito Nakano, Hideki Iwamoto, Masatoshi Tanaka, Takaaki Tanaka, Kazunori Noguchi, Hajime Aino, Kei Ogata, Masahiko Kajiwara, Satoshi Itano, Yoshinori Yokokura, Taizo Yamaguchi, Hiroshi Kawano, Norito Matsukuma, Hideya Suga, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Takumi Kawaguchi, Hironori Koga, Takuji Torimura
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8530-8541 (2021)
Abstract Background and Aims Sequential therapy with molecular‐targeted agents (MTAs) is considered effective for unresectable hepatocellular carcinoma (HCC) patients. This study purposed to evaluate the efficacy of sequential therapy with sorafeni
Externí odkaz:
https://doaj.org/article/0894e9642c0c4631b38c4aa5d3985b9c
Autor:
Masahiko Kajiwara, Hironori Koga, Takumi Kawaguchi, Taizo Yamaguchi, Hideya Suga, Yu Noda, Shusuke Okamura, Masatoshi Tanaka, Atsushi Hiraoka, Takaaki Tanaka, Takuji Torimura, Tomotake Shirono, Naoki Kamachi, Hiroshi Kawano, Masahito Nakano, Takashi Niizeki, Satoshi Itano, Shigeo Shimose, Kazunori Noguchi, Yoshinori Yokokura, Hajime Aino, Kei Ogata, Hideki Iwamoto, Norito Matsukuma
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8530-8541 (2021)
Cancer Medicine
Cancer Medicine
Background and Aims Sequential therapy with molecular‐targeted agents (MTAs) is considered effective for unresectable hepatocellular carcinoma (HCC) patients. This study purposed to evaluate the efficacy of sequential therapy with sorafenib (SORA)
Autor:
Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Etsuko Moriyama, Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4284
This study aimed to evaluate the correlation between adverse events (AEs) and overall survival (OS) in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab (atezo/beva). This was a multicenter study in which
Autor:
Hideki, Iwamoto, Takashi, Niizeki, Hiroaki, Nagamatsu, Kazuomi, Ueshima, Takako, Nomura, Teiji, Kuzuya, Kazuhiro, Kasai, Yohei, Kooka, Atsushi, Hiraoka, Rie, Sugimoto, Takehiro, Yonezawa, Akio, Ishihara, Akihiro, Deguchi, Hirotaka, Arai, Shigeo, Shimose, Tomotake, Shirono, Masahito, Nakano, Shusuke, Okamura, Yu, Noda, Naoki, Kamachi, Miwa, Sakai, Hiroyuki, Suzuki, Hajime, Aino, Norito, Matsukuma, Satoru, Matsugaki, Kei, Ogata, Yoichi, Yano, Takato, Ueno, Masahiko, Kajiwara, Satoshi, Itano, Kunitaka, Fukuizumi, Hiroshi, Kawano, Kazunori, Noguchi, Masatoshi, Tanaka, Taizo, Yamaguchi, Ryoko, Kuromatsu, Atsushi, Kawaguchi, Hironori, Koga, Takuji, Torimura, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan
Publikováno v:
Cancers
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
BACKROUND: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemothera
Autor:
Hideki Iwamoto, Manabu Satani, Hironori Koga, Nobuyoshi Tajiri, Shusuke Okamura, Takuji Torimura, Junichi Kurogi, Ryoko Kuromatsu, Masahiko Kajiwara, Shuji Sumie, Satoshi Matsugaki, Shigeo Shimose, Hiroaki Nagamatsu, Masahito Nakano, Takashi Niizeki, Hajime Aino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 77:243-250
Portal vein tumor thrombosis is a critical complication in patients with hepatocellular carcinoma (HCC). This prospective multicenter trial assessed the efficacy of hepatic arterial infusion chemoembolization therapy with cisplatin suspended in lipio
Autor:
Kunihide Ishii, Michio Sata, Tomotake Shirono, Hirohiko Abe, Shinji Baba, Jun Taguchi, Masahiko Kajiwara, Mahiro Imamura, Osamu Nakashima, Hiroshi Takaki, Hirohisa Yano
Publikováno v:
Kanzo. 51:664-673
Autor:
Hiroyuki KOGA, Jun TAGUCHI, Kunihide ISHII, Kinya INOUE, Kimiaki SATOU, Toshiaki SANEFUJI, Masahiko KAJIWARA, Hirohiko ABE, Ryukichi KUMASHIRO, Michio SATA
Publikováno v:
Kanzo. 44:117-122
Autor:
Hiroyuki KOGA, Jun TAGUCHI, Akihiro IEMURA, Masahiko KAJIWARA, Kinya INOUE, Akiko ISHIBASHI, Shin-ichi KUBOYAMA, Kunihide ISHII, Hirohiko ABE, Yoshiaki TUJI, Osamu NAKASHIMA, Masamichi KOJIRO, Riko HARADA, Michio SATA
Publikováno v:
Kanzo. 43:459-464
Publikováno v:
Biological and Pharmaceutical Bulletin. 21:530-534
i-OHAP, a major metabolite of aprindine (AP), was isolated by TLC from rat feces and identified as N-13-(N,N-diethylamino)propyl]-N-phenyl-2-aminoindan-5-ol, based on 1H-NMR, the H-H correlation spectroscopy (COSY) spectrum, MS and LC-MS. Its structu